0001104659-25-094758 Sample Contracts

37,909,018 Shares Ocular Therapeutix, Inc. UNDERWRITING AGREEMENT

Underwriting Agreement • September 30th, 2025 • Ocular Therapeutix, Inc • Pharmaceutical preparations • New York

• Contract Type
  Underwriting Agreement
• Filed
  September 30th, 2025
• Company
  Ocular Therapeutix, Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Introductory. Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 37,909,018 shares of its common stock, par value $0.0001 per share (the “Shares”). The 37,909,018 Shares to be sold by the Company are called the “Firm Shares.” BofA Securities, Inc. (“BofA”), TD Securities (USA) LLC (“TD Cowen”) and Piper Sandler & Co. (“Piper”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Firm Shares. To the extent there are no additional underwriters listed on Schedule A, the term “Representatives” as used herein shall mean you, as Underwriters, and the term “Underwriters” shall mean either the singular or the plural, as the context requires.